JustMilk consists of a US non-profit and a UK for-profit organisation developing the Nipple Shield Delivery System (NSDS), a novel medical device with the potential to improve the safety, efficacy and access to life-saving medications, vitamins and nutrients to breastfeeding infants globally.
When worn by a mother during breastfeeding, the NSDS releases active pharmaceutical agents into milk which is then consumed by the infant. A wide range of medications and nutrients could be delivered to infants for treatment or prevention of conditions which may include diarrhoeal disease, HIV, malaria or malnutrition.
With the NSDS, JustMilk aims to bridge a global drug delivery technology gap for breastfeeding infants, particularly in developing countries where it could overcome conventional administration challenges associated with limited availability of potable water, refrigeration, and medical care. JustMilk is currently seeking pharmaceutical partners.
Watch JustMilk in discussion with Luther Phillips:
Get in touch
News about JustMilk
JustMilk wins national McKinsey Venture Academy competition.
Research centre news
Cambridge entrepreneurship
Three ventures supported by the Accelerate Cambridge programme at Cambridge Judge Business School to pitch at finals of Pitch@Palace.
Can you pitch your genius business idea in the time it takes to get from the ground floor to the C-suite? JustMilk's Rebekah Scheuerle, on the CJBS Accelerate Cambridge programme, takes on the challenge.